Back

Comparisons in cardiovascular outcomes and mortality in patients diagnosed with hypertrophic cardiomyopathy

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease 4 Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Nosheen Reza

Hospital of the University of Pennsylvania, Philadelphia (United States of America)

6 More presentations in this session

Presentation thumbnail
Late gadolinium enhancement regression in the follow-up of acute myocarditis episodes
Doctor A. Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Associations between sex and cardiovascular outcomes in patients with hypertrophic cardiomyopathy
Doctor N. Reza (Philadelphia, US)
Abstract Slides Video
Presentation thumbnail
Direct abnormal communications between septal perforator arteries and cardiac chambers: a potential source of serious complications during alcohol septal ablation in hypertrophic cardiomyopathy
Doctor R. Sepp (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Comparison of clinical and echocardiographic characteristics before and after septal myectomy in patients with hypertrophic cardiomyopathy in a reference hospital in Colombia
Doctor L. Lopez Gutierrez (Medellin, CO)
Abstract Slides Video
Presentation thumbnail
Natural history of TNNT2 gene mutation carriers with familial hypertrophic cardiomyopathy: a long follow up study
Doctor C. Gregorio (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in myocardial disease 4

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Associations between sex and cardiovascular outcomes in patients with hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Clinical burden of obstructive and non-obstructive hypertrophic cardiomyopathy: insights from a nationwide study in France
thumbnail
Congress Presentation
Characteristics and long-term outcomes of asymptomatic patients with hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources